Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach
Author:
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.23275/fullpdf
Reference48 articles.
1. Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy;Xu;Neuro-Oncol,2004
2. New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study;Neglia;J Natl Cancer Inst,2006
3. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma;Mulhern;J Clin Oncol,2005
4. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): Report of the Head Start I and II experience;Fangusaro;Pediatr Blood Cancer,2008
5. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue;Zacharoulis;Pediatr Blood Cancer,2007
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Late effects of medulloblastoma treatment: multidisciplinary approach of survivors;Child's Nervous System;2023-09-12
2. Neurocognitive Dysfunction After Treatment for Pediatric Brain Tumors: Subtype-Specific Findings and Proposal for Brain Network-Informed Evaluations;Neuroscience Bulletin;2023-08-24
3. Radiotherapy-Induced Neurocognitive Dysfunction in Brain Tumor Survivors: Burden and Rehabilitation;Acta Neurochirurgica Supplement;2023
4. Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis;Cancer Epidemiology;2022-08
5. The Incidence and Risk Factors of Cisplatin and Carboplatin Ototoxicity in Pediatric Oncology Patients at Tertiary Oncology Center;Indian Journal of Surgical Oncology;2022-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3